
MDxHealth SA – NASDAQ:MDXH
MDxHealth SA stock price today
MDxHealth SA stock price monthly change
MDxHealth SA stock price quarterly change
MDxHealth SA stock price yearly change
MDxHealth SA key metrics
Market Cap | 109.88M |
Enterprise value | 63.91M |
P/E | -1.12 |
EV/Sales | 1.50 |
EV/EBITDA | -1.75 |
Price/Sales | 0.93 |
Price/Book | 4.25 |
PEG ratio | 0.02 |
EPS | -1.46 |
Revenue | 75.32M |
EBITDA | -21.82M |
Income | -39.90M |
Revenue Q/Q | 34.92% |
Revenue Y/Y | 65.01% |
Profit margin | -112.66% |
Oper. margin | -93.55% |
Gross margin | 54.16% |
EBIT margin | -93.55% |
EBITDA margin | -28.98% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMDxHealth SA stock price history
MDxHealth SA stock forecast
MDxHealth SA financial statements
Jun 2023 | 16.74M | -10.62M | -63.46% |
---|---|---|---|
Sep 2023 | 19.35M | -10.04M | -51.91% |
Dec 2023 | 19.39M | -10.72M | -55.26% |
Mar 2024 | 19.83M | -8.51M | -42.91% |
Mar 2024 | 19.83M | -8.51M | -42.91% |
---|---|---|---|
Sep 2025 | 24.22M | -4.38M | -18.11% |
Dec 2025 | 24.34M | -3.16M | -13.01% |
Dec 2025 | 25.79M | -3.68M | -14.3% |
Analysts Price target
Financials & Ratios estimates
2022-11-09 | -0.00481 | -0.05 |
---|---|---|
2022-12-31 | -1.41137 | -1.02005 |
2023-03-09 | -1.85295 | -1.1 |
Jun 2023 | 142545000 | 115.88M | 81.3% |
---|---|---|---|
Sep 2023 | 135733000 | 117.88M | 86.85% |
Dec 2023 | 129132000 | 121.92M | 94.42% |
Mar 2024 | 121745000 | 122.71M | 100.8% |
Jun 2023 | -5.59M | -1.57M | -1.42M |
---|---|---|---|
Sep 2023 | -4.26M | -439K | -2.26M |
Dec 2023 | -7.75M | -954.57K | -2.29M |
Mar 2024 | -6.31M | -764K | -805K |
MDxHealth SA alternative data
Aug 2023 | 252 |
---|---|
Sep 2023 | 252 |
Oct 2023 | 252 |
Nov 2023 | 252 |
Dec 2023 | 252 |
Jan 2024 | 252 |
Feb 2024 | 252 |
Mar 2024 | 252 |
Apr 2024 | 252 |
May 2024 | 252 |
Jun 2024 | 300 |
Jul 2024 | 300 |
MDxHealth SA other data
Period | Buy | Sel |
---|---|---|
Feb 2023 | 1000000 | 0 |
Quarter | Transcript |
---|---|
Q1 2024 1 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 6 Mar 2024 | Q4 2023 Earnings Call Transcript |
-
What's the price of MDxHealth SA stock today?
One share of MDxHealth SA stock can currently be purchased for approximately $2.9.
-
When is MDxHealth SA's next earnings date?
Unfortunately, MDxHealth SA's (MDXH) next earnings date is currently unknown.
-
Does MDxHealth SA pay dividends?
No, MDxHealth SA does not pay dividends.
-
How much money does MDxHealth SA make?
MDxHealth SA has a market capitalization of 109.88M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 89.43% to 70.19M US dollars. MDxHealth SA made a loss 43.1M US dollars in net income (profit) last year or -$1.1 on an earnings per share basis.
-
What is MDxHealth SA's stock symbol?
MDxHealth SA is traded on the NASDAQ under the ticker symbol "MDXH".
-
What is MDxHealth SA's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of MDxHealth SA?
Shares of MDxHealth SA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does MDxHealth SA have?
As Jul 2024, MDxHealth SA employs 300 workers, which is 19% more then previous quarter.
-
When MDxHealth SA went public?
MDxHealth SA is publicly traded company for more then 3 years since IPO on 4 Nov 2021.
-
What is MDxHealth SA's official website?
The official website for MDxHealth SA is mdxhealth.com.
-
How can i contact MDxHealth SA?
MDxHealth SA can be reached via phone at +32 4 257 70 21.
MDxHealth SA company profile:

MDxHealth SA
mdxhealth.comNASDAQ
300
Medical - Diagnostics & Research
Healthcare
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Herstal, 4040
CIK: 0001872529
ISIN: US58286E1029
CUSIP: 58286E102